Kisspeptin regulation of male sex development: possibilities of diagnosis and treatment of delayed puberty and hypogonadotropic hypogonadism
https://doi.org/10.14341/probl9360
Abstract
Background. Kisspeptin system plays an important role in the neuroendocrine control of gonadotropin secretion, sexual differentiation of the brain, puberty, and fertility.
Objective — the study was aimed at assessing blood level of Kisspeptin in healthy boys, depending on puberty stage, as well as in boys with pathological delay of puberty onset.
Material and methods. The study included 43 somatically healthy boys. Group 1 consisted of 12 boys 14—17 years old with delayed puberty, group 2 included 16 boys 14—18 years old with normal puberty, Tanner stage IV — V, group 3 — 15 boys 6—10 years old, Tanner stage I. In group 1, median testosterone level (T) was 0.09 nmol/l, LH — 0.3 IU/l; the peak LH level in the triptorelin test was below 5 IU/l in 50% of this group. Serum level of kisspeptin was assessed by ELISA using a specific kit.
Results. Median serum level of kisspeptin (34.8 pg/ml) was significantly (p>0.05) higher in in the group with delayed puberty than in the groups with age-appropriate sexual development. There were no differences between groups 2 and 3 in this value.
Conclusion. Serum level of kisspeptin, which is low in the case of physiological sexual development (regardless of stage), significantly increases in boys with delayed puberty onset, which can be used as a diagnostic marker of this pathology. The results suggest attenuated effect of kisspeptin due to decrease in its biological activity or decrease in sensitivity of the kisspeptin receptors in the case of delayed puberty and hypogonadism. The possibility of treatment of male hypogonadism with exogenous kisspeptin cannot be ruled out.
About the Authors
Irina L. NikitinaAlmazov National Medical Research Center
Russian Federation
MD, PhD
Yuliya N. Yuchlina
Almazov National Medical Research Center
Russian Federation
Elena Y. Vasileva
Almazov National Medical Research Center
Russian Federation
Irena I. Nagornaya
Almazov National Medical Research Center
Russian Federation
MD, PhD
References
1. Abreu AP, Kaiser UB. Pubertal development and regulation. Lancet Diabetes Endocrinol. 2016;4(3):254-264. doi: https://doi.org/10.1016/s2213-8587(15)00418-0
2. Ojeda SR, Lomniczi A, Sandau U, Matagne V. New concepts on the control of the onset of puberty. Endocr Dev. 2010;17:44-51. doi: https://doi.org/10.1159/000262527
3. Ojeda SR, Terasawa E. Neuroendocrine regulation of puberty. In: Pfaff D, Arnold A, Etgen A, Et Al, Editors. Hormones, Brain And Behavior. Vol. 4. New York: Elsevier; 2002;589-659. doi: https://doi.org/10.1016/b978-012532104-4/50077-9
4. Lomniczi A, Ojeda Sr. The emerging role of epigenetics in the regulation of female puberty. Endocr Dev. 2016;29:1-16. doi: https://doi.org/10.1159/000438840
5. Willemsen RH, Dunger DB. Normal variation in pubertal timing: genetic determinants in relation to growth and adiposity. Endocr Dev. 2016;29:17-35. doi: https://doi.org/10.1159/000438957
6. Ярмолинская М.И., Ганбарли Н.Ф., Айламазян Э.К. Значение Кисспептина в регуляции функции репродуктивной системы. // Журнал акушерства и женских болезней. — 2016. — Т. 65. — № 6. — С. 4-18. [Yarmolinskaya MI, Ganbarli NF, Aylamazyan EK. Role of kisspeptine in regulation of reproductive function. Journal of Obstetrics and Women’s Diseases. 2016;65(6):4-18. (In Russ.)]. doi: https://doi.org/10.17816/jowd6564-18
7. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011;96(8):E1228-E1236. doi: https://doi.org/1210/jc.2011-0089
8. Chan YM, Butler JP, Pinnell NE, et al. Kisspeptin resets the hypothalamic GNRH clock in men. J Clin Endocrinol Metab. 2011;96(6):E908-E915. doi: https://doi.org/10.1210/jc.2010-3046
9. Jayasena CN, Abbara A, Narayanaswamy S, et al. Direct comparison of the effects of intravenous Kisspeptin-10, Kisspeptin-54 and GNRH on gonadotrophin secretion in healthy men. Hum Reprod. 2015;30(8):1934-1941. doi: https://doi.org/10.1093/humrep/dev143
10. Narayanaswamy S, Jayasena CN, NGN, et al. Subcutaneous infusion of Kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels. Clin Endocrinol (Oxf). 2016;84(6):939-945. doi: https://doi.org/10.1111/cen.12977
11. Ranke MB, Mullis P-E (eds.). Diagnostics of Endocrine Function in Children and Adolescents. 4th Ed. Basel: Karger; 2011.
12. Никитина И.Л., Ходулева Ю.Н., Масель А.С. и др. Cистема Kiss/Kiss1r: периферический сигналинг в андрогензависимых тканях в модели мужского гипогонадизма. // Патологическая физиология и экспериментальная терапия. — 2016. — Т. 60. — № 4. — С. 24-33. [Nikitina IL, Khoduleva YuN, Masel AS, et al. System of Kiss-Kiss1r: focus on peripheral signaling in androgen-dependend tissues in the experimentally induced model hypogonadotropic hypogonadism. Patol Fiziol Eksp Ter. 2016;60(4):24-33. (In Russ.)].
13. Seminara SB, Dipietro MJ, Ramaswamy S, et al. Continuous human Metastin 45-54 infusion desensitizes G protein-coupled receptor 54-inducedgGonadotropin-releasing hormone release monitored indirectly in the juvenile male rhesus monkey (Macaca Mulatta): a finding with therapeutic implications. Endocrinology. 2006;147(5):2122-2126. doi: https://doi.org/10.1210/en.2005-1550
14. Ramaswamy S, Seminara SB, Pohl CR, et al. Effect of continuous intravenous administration of human metastin 45—54 on the neuroendocrine activity of the hypothalamic-pituitary-testicular axis in the adult male rhesus monkey (Macaca Mulatta). Endocrinology. 2007;148(7):3364-3370. doi: https://doi.org/10.1210/en.2007-0207
Supplementary files
Review
For citations:
Nikitina I.L., Yuchlina Yu.N., Vasileva E.Y., Nagornaya I.I. Kisspeptin regulation of male sex development: possibilities of diagnosis and treatment of delayed puberty and hypogonadotropic hypogonadism. Problems of Endocrinology. 2018;64(5):280-285. https://doi.org/10.14341/probl9360

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).